Black Diamond Therapeutics Inc — movimiento de fondos (NASDAQ:BDTX) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas -52.15 M-100.15 M-85.08 M-66.72 M-62.3 M29.61 M 29.61 M Flujo de caja de las actividades de inversión -281.69 M130.61 M53.37 M16.35 M16.97 M-44.91 M -44.91 M Flujo de caja de las actividades financieras 214.94 M729 K177 K71.93 M25.55 M-146 K -146 K Flujo de caja libre -52.29 M-102.86 M-85.27 M-66.75 M-62.3 M29.61 M 29.61 M

Noticias

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026

Black Diamond Stock: Weighing Catalysts vs. Concentration

BDTX: What Silevertinib Data Say About EGFR NSCLC Upside

Black Diamond Therapeutics: Market Yawning About Data, But I See Opportunity (BDTX)

Freedom Capital Markets eleva precio objetivo de Black Diamond por datos de ensayo

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

What Makes Black Diamond (BDTX) a New Strong Buy Stock

New Strong Buy Stocks for January 9th

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

Stifel reitera calificación de compra para Black Diamond Therapeutics a $8

Stifel reitera calificación de Compra para acciones de Black Diamond Therapeutics a 8 dólares